Keloid clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids
Sorry, in progress, not accepting new patients
Keloids are a common form of hypertrophic scars that by definition last beyond 6 months and grow beyond the site of initial injury. Keloids are a common complaint from patients in dermatology and cause significant functional impairment due to…
San Diego, California
Our lead scientists for Keloid research studies include Arisa Ortiz.
Last updated: